Takeda Pharmaceutical Co. Ltd. (TKPYY) Initiates TOURMALINE-MM2 Pivotal Phase 3 Trial of MLN9708 in Patients With Newly Diagnosed Multiple Myeloma
5/23/2013 11:04:43 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY) Recalls Batch of Anemia Therapy Rienso in Switzerland After Patient Death
5/22/2013 8:14:01 AM
More...
|
Millennium Pharmaceuticals, Inc. CEO Out as Takeda Pharmaceutical Co. Ltd. (TKPYY) Reorganizes, Cuts Costs
5/10/2013 7:29:50 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY) Announces Financial Results for the Fiscal Year Ended March 31, 2013 and Forecasts for the Fiscal Year Ending March 31, 2014
5/9/2013 6:47:53 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY) Snaps Up InViragen for Up to $250 Million
5/8/2013 7:20:18 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY) Gets $6.5 Million Diabetes-Drug Verdict Thrown Out
5/2/2013 8:13:39 AM
More...
|
Heptares Achieves All Research Milestones and Receives Milestone Payment From GPCR Drug Discovery Agreement With Takeda Pharmaceutical Co. Ltd. (TKPYY)
4/29/2013 8:28:30 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY) and Sanofi (France) (SAN.PA) Strike Diabetes Drug Co-Promotion in China
4/25/2013 9:18:47 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY) Penalized Over Quality Failure
4/19/2013 11:00:01 AM
More...
|
Agreement on Molecular Design of Small Molecule Protein-Protein Interaction (PPI) Inhibitor Between Interprotein and Takeda Pharmaceutical Co. Ltd. (TKPYY)
4/19/2013 10:42:56 AM
More...
|
|